top of page

Trend Reports

Alcohol and Opioid Addiction

The Alcohol and Opioid Addiction Trend Report sponsored by Alkermes

Cardiology

Sanofi-aventis Atrial Fibrillation Data Brief (6 regional reports)

Dermatology

The Galderma Quality Report for Dermatology and Managed Care, Vol. II

Renew Advantage Aesthetic Dermatology and Plastic Surgery Loyalty Trend Report

Diabetes

The Novo Nordisk Diabetes Care Report: Partnering To Address Diabetes

Eye Care

The Eye Care Trend Report Supported By Allergan (Vol. I, II & III)

Gastroenterology

The Ferring Pharmaceuticals Gastroenterology Practice Management Report

Infertility

The Ferring Managed Care Trend Report for Infertility

Neurology & Senior Care

The Prescription Drug Benefit Cost and Plan Design Survey Report Provided by Takeda

The Ferring Managed Care Trend Report for Osteoarthritis

The Boehringer Ingelheim Pharmacy Benefits Report

The Boehringer Ingelheim Medicare Part D & Patient-Centered Medical Home Report

The UCB Parkinson’s Report: for Managed Care, Neurology & Senior Care Decision-Makers 

Chronic Pain Care Trends: Perspectives from Managed Care, Providers, and Employers 

The Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers, and Patients (sponsored by Teva Neuroscience & the National MS Society from 2006 to the present)

Sanofi-aventis Senior Care Digest Interdisciplinary Report: A Survey of Long-Term-Care Health Professionals

Biologics Trend Report Sponsored by UCB

Oncology

The Genentech Oncology Trend Report
Sanofi-aventis Oncology Cancer Care Report (5 regional reports)
Sanofi-aventis Atrial Fibrillation Data Brief (6 regional reports)

Newsletters

Allergy, Asthma

The American College of Allergy, Asthma & Immunology Practice Management Update

Dermatology

The Maruho Derma Report (newsletter for a few thousand Japanese dermatologists)

ACAAI Practice Management Update

The National Psoriasis Foundation

Reports on the 2016 AAD Meeting,

Supported by Novartis: The Role of IL-17 in Psoriasis

American Academy of Dermatology 77th Annual Meeting Highlights

Diabetes

Novo Nordisk Diabetes Care Report

Novo Nordisk Best Practices in Diabetes Management: Spotlight on Rapid-Acting Insulin Analogs

Novo Nordisk Best Practices in Diabetes Management: Spotlight on Long-Acting Analog Basal Insulins

Novo Nordisk Best Practices in Diabetes Management: NovoRapid Bolus Insulin Helps Diabetics Fast During Ramadan

Novo Nordisk Best Practices in Diabetes Management: Spotlight on Hypoglycemia

Novo Nordisk Best Practices in Diabetes Management: Rethinking the Role of Carbohydrates 

Novo Nordisk Best Practices in Diabetes Management: With Guidance, Many Diabetes Patients Can Safely Fast During Ramadan 

Novo Nordisk Best Practices in Diabetes Management: Strategies To Prevent and Manage Hypoglycemia 

Novo Nordisk Best Practices in Diabetes Management: New Basal Insulin Offers Flexible Dosing, Other Benefits 

Novo Nordisk Best Practices in Diabetes Management: Novo Nordisk’s Tresiba® Basal Insulin Enters the Saudi Arabia Market and is Well-Received

Novo Nordisk Best Practices in Diabetes Management: Insulin Degludec Tresiba® Will Help Keep Ramadan Fasting Safe

The Introduction of Tresiba® Adds A Powerful Tool to Diabetes Therapy: What Saudi Endocrinologists Are Saying About Tresiba®

Ramadan Expert opinion interview: Focus on Gliclazide supported by Servier

In Clinical Studies and Real-World Use, Tresiba® Boasts Its Status as Best Basal Insulin

TRESIBA® AND XULTOPHY® EQUIP ENDOCRINOLOGISTS WITH TWO POWERFUL DIABETES DRUGS: In Real-World Practice, Endocrinologists Praise Novo Nordisk’s Tresiba® and Xultophy

Senior Care

Management in Long-Term Care

bottom of page